{
  "nctId": "NCT02608177",
  "briefTitle": "Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management",
  "officialTitle": "Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management",
  "protocolDocument": {
    "nctId": "NCT02608177",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2015-09-28",
    "uploadDate": "2018-08-09T13:07",
    "size": 475505,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02608177/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "CROSSOVER",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 3,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-11",
    "completionDate": "2018-08",
    "primaryCompletionDate": "2017-08",
    "firstSubmitDate": "2015-11-16",
    "firstPostDate": "2015-11-18"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Type 2 diabetes\n* eGFR 15-59 mL/min/1.73 m2\n* Hemoglobin A1c \\< 8%\n* Age â‰¥ 18 years\n* Current use of sulfonylurea\n\nExclusion Criteria:\n\n* BMI \\> 40 kg/m2\n* Actively using CGM for clinical care\n* End stage renal disease needing dialysis\n* Kidney transplant\n* Pregnant or nursing\n* Unable to provide informed consent",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Glucose Time in Range",
        "description": "Time with glucose 70-140 mg/dL",
        "timeFrame": "last 6 days of each 28-day treatment period"
      }
    ],
    "secondary": [
      {
        "measure": "Glycemic Variability",
        "description": "SD of glucose readings",
        "timeFrame": "last 6 days of each 28-day treatment period"
      },
      {
        "measure": "Hypoglycemia",
        "description": "Glucose \\<70 mg/dL for at least 10 minutes",
        "timeFrame": "last 6 days of each 28-day treatment period"
      },
      {
        "measure": "Biomarkers of Systemic Inflammation",
        "description": "Measured by plasma C-reactive protein (CRP)",
        "timeFrame": "last 6 days of each 28-day treatment period"
      },
      {
        "measure": "Biomarkers of Systemic Inflammation",
        "description": "Measured by plasma interleukin-6",
        "timeFrame": "last 6 days of each 28-day treatment period"
      },
      {
        "measure": "Biomarkers of Oxidative Stress",
        "description": "Measured by plasma F2-isoprostanes",
        "timeFrame": "last 6 days of each 28-day treatment period"
      },
      {
        "measure": "Biomarkers of Oxidative Stress",
        "description": "Measured by urine F2-isoprostanes",
        "timeFrame": "last 6 days of each 28-day treatment period"
      },
      {
        "measure": "Biomarkers of Albuminuria",
        "description": "Measured by albumin-creatinine ratio",
        "timeFrame": "last 6 days of each 28-day treatment period"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 7,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "CROSSOVER"
    },
    "overallComplexityScore": 74,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:07.249Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}